Abstract:Schizophrenia is a severe neuropsychiatric disorder with core features including hallucinations, delusions, and cognition deficits. Accumulating evidence has implicated abnormal DNA methylation in the development of schizophrenia. However, the mechanisms by which DNA methylation changes alter the risk for schizophrenia remain largely unknown. We recently carried out a DNA methylome study of peripheral blood samples from 469 first-episode patients with schizophrenia and 476 age- and gender-matched healthy controls of Han Chinese origin. Genomic DNA methylation patterns were quantified using an Illumina Infinium Human MethylationEPIC BeadChip. We identified multiple differentially methylated positions (DMPs) and regions between patients and controls. The most significant DMPs were annotated to genes C17orf53, THAP1 and KCNQ4 (KV7.4), with Bonferroni-adjusted P values of ({mathrm{1}}{mathrm{.34}} imes {mathrm{10}}^{{mathrm{ - 12}}}), ({mathrm{1}}{mathrm{.15}} imes {mathrm{10}}^{{mathrm{ - 11}}}), and ({mathrm{3}}{mathrm{.11}} imes {mathrm{10}}^{{mathrm{ - 11}}}), respectively. In particular, KCNQ4 encodes a voltage-gated potassium channel of the KV7 family, which is linked to neuronal excitability. The genes associated with top-ranked DMPs also included many genes involved in nervous system development, such as LIMK2 and TMOD2. Gene ontology analysis of the differentially methylated genes further identified strong enrichment of neuronal networks, including neuron projection extension, axonogenesis and neuron apoptotic process. Finally, we provided evidence that schizophrenia-associated epigenetic alterations co-localize with genetic susceptibility loci. By focusing on first-episode schizophrenia patients, our investigation lends particularly strong support for an important role of DNA methylation in schizophrenia pathogenesis unconfounded by the effects of long-term antipsychotic medication or disease progression. The observed DNA methylation aberrations in schizophrenia patients could potentially provide a valuable resource for identifying diagnostic biomarkers and developing novel therapeutic targets to benefit schizophrenia patients.

Effects of flunixin meglumine on cardiopulmonary responses to endotoxin in ponies.

DNA Methylation in Schizophrenia: Progress and Challenges

Hypomethylation of LINE-1 elements in schizophrenia and bipolar disorder

Computer-aided image-guided endoscopic sinus surgery in unusual cases of sphenoid disease.

Genome-wide analysis of DNA methylation in 106 schizophrenia family trios in Han Chinese

Chromatin Profiling in Human Neurons Reveals Aberrant Roles for Histone Acetylation and BET Family Proteins in Schizophrenia

Genome-wide DNA methylation analysis of peripheral blood cells derived from patients with first-episode schizophrenia in the Chinese Han population

DNA Hyper-methylation Associated with Schizophrenia May Lead to Increased Levels of Autoantibodies

DNA hyper-methylation associated with schizophrenia may lead to breakdown of self-tolerance

Altered DNA methylation associated with a translocation linked to major mental illness

Psychotic symptoms associated increased CpG methylation of metabotropic glutamate receptor 8 gene in Chinese Han males with schizophrenia and methamphetamine induced psychotic disorder: a longitudinal study

Drug Response-Related DNA Methylation Changes in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder

The DNA Methylation Profile Within the 5′-Regulatory Region of DRD2 in Discordant Sib Pairs with Schizophrenia

Allele-specific DNA methylation maps in monozygotic twins discordant for psychiatric disorders reveal that disease-associated switching at the EIPR1 regulatory loci modulates neural function

Linkage disequilibrium mapping of chromosome 22 in schizophrenia using DNA pooling on Chinese and Scottish populations

Transition of allele-specific DNA hydroxymethylation at regulatory loci is associated with phenotypic variation in monozygotic twins discordant for psychiatric disorders

Investigating the relationship between DNA methylation, genetic variation, and suicide attempt in bipolar disorder

Association Between Schizophrenia and DNA Demethylase Activity in Human Peripheral Blood Mononuclear Cells

Genome-wide DNA Methylation Analysis in Families with Multiple Individuals Diagnosed with Schizophrenia and Intellectual Disability.

Quantitative DNA Methylation Analysis of DLGAP2 Gene Using Pyrosequencing in Schizophrenia with Tardive Dyskinesia: A Linear Mixed Model Approach.

Allelic differences between Europeans and Chinese for CREB1 SNPs and their implications in gene expression regulation, hippocampal structure and function, and bipolar disorder susceptibility